A recent study reported that serum FGF21 concentrations were significantly associated with SBP, DBP, BMI, serum TG, and fasting glucose levels in a Japanese adult population without metabolic disorders medication, suggesting that an FGF21 compensatory response to metabolic stress or resistance is associated with “metabolic imbalance” [26]. Here, FGF21 is linked to Other metabolic disease.